Page 4 - Jubilant Pharmova News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Alkem Laboratories Q4 Results: Profit jumps multi-fold to Rs 293 56 crore, final dividend of Rs 5 announced

Alkem Laboratories Q4 Results: Profit jumps multi-fold to Rs 293 56 crore, final dividend of Rs 5 announced
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

United statesVikas guptaAlkem laboratorieDonear industriesReliance communicationsBoston consulting groupTata steelOther internationalAlkem laboratoriesAnnual generalBata indiaJubilant pharmovaLiberty shoesConsulting groupIndian pharmaceutical marketInternational markets

Jubilant Pharmova Q4 net profit jumps over two-fold to Rs 61 crore

Jubilant Pharmova Chairman Shyam S Bhartia said that in the generics business, the company is growing profitably in the non US international markets.

Shyams bhartiaContract development manufacturing organizationJubilant pharmovaPharmova chairman shyams bhartiaContract developmentManufacturing organization

Retailers in Telangana witness over 1100% growth in ecommerce transactions, reveals report

Retailers in Telangana witness over 1100% growth in ecommerce transactions, reveals report
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Uttar pradeshJammu and kashmirMadhya pradeshAndhra pradeshUnited statesAnand kumar bajajViksit bharatBoston consulting groupTata steelDonear industriesReliance communicationsAtmanirbhar bharat digital empowermentBata indiaJubilant pharmovaLiberty shoesConsulting group

Jubilant Pharmova s Profits Surge Over Two-Fold in Q4 2024

Jubilant Pharmova reported a more than two-fold increase in consolidated profit after tax, reaching Rs 61 crore for Q4 2024. The company's total income from operations stood at Rs 1,773 crore. For the full fiscal year, net profit surged to Rs 195 crore, with significant growth plans announced for international and US markets.

Shyams bhartiaContract development manufacturing organizationJubilant pharmovaPharmova chairman shyams bhartiaContract developmentManufacturing organization

Radiopharmaceuticals Market to Reach $21 8 billion, Globally, by 2033 at 10 6% CAGR: Allied Market Research

PORTLAND, Ore., May 29, 2024 /PRNewswire/ Allied Market Research published a report, titled, "Radiopharmaceuticals Market by End User (Hospitals and Clinics, Medical Imaging Centers, and

United statesHong kongUnited kingdomDavid correaPawan kumarEli lillySemiconductor electronicsImaging centersAerospace defenseJubilant pharmovaAfrican nuclear energy corporation necsaTelix pharmaceuticalsCardinal healthBusiness intelligence solutionsLife sciencesPrnewswire allied market research